MicroRNAs Let-7b-5p and miR-24-3p as Potential Therapeutic Agents Targeting Pancreatic Cancer Stem Cells
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262211066 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Maricela Medrano-Silva und 15 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Biomedicina Molecular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV-IPN), Apartado P…. Hauptthemen laut MEDLINE: MicroRNAs, Neoplastic Stem Cells, Pancreatic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Secretaría de Ciencia, Humanidades, Tecnología e Innovación, Consejo Nacional de Ciencia y Tecnología fellowship.
Abstract (Originalsprache)
Pancreatic cancer poses a major clinical challenge due to its aggressiveness, frequent recurrence, and limited response to current chemotherapeutic approaches. Cancer stem cells (CSCs), particularly pancreatic CSCs (PCSCs), are key drivers of tumor initiation, therapeutic resistance, and disease relapse. MicroRNAs (miRNAs) have emerged as critical regulators of CSC biology and influence self-renewal, pluripotency, and drug resistance through key signaling pathways. To identify PCSC-specific miRNAs, we enriched these cells using the pancreosphere culture method and isolated PCSC+ and PCSC− populations using FACS based on their expression of CD44, CD24, and CD133 surface markers. MicroRNA microarray analysis revealed 31 differentially expressed miRNAs (DEmiRNAs), of which 10 downregulated miRNAs were involved in pathways regulating pluripotency, including the Wnt/β-catenin, TGF-β, MAPK, and PI3K/AKT pathways. Then, 2 of these 10 DEmiRNAs, let-7b-5p and miR-24-3p, were selected for experimental validation. Their overexpression in PCSC+ cells inhibited these pathways, downregulated pluripotency factors, and induced differentiation into endocrine and exocrine phenotypes, as confirmed by RT-qPCR, Western blot, and RNA-seq. Functionally, each miRNA reduced sphere formation, increased gemcitabine sensitivity, and suppressed tumorigenicity in vivo, highlighting their potential as therapeutic candidates. Restoring tumor-suppressive miRNA expression may offer a novel strategy to overcome chemoresistance and improve outcomes in pancreatic cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Biomedicina Molecular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV-IPN), Apartado Postal 14-740, Ciudad de México 07360, Mexico.
- Departamento de Ciencias Naturales, Universidad Autónoma Metropolitana Unidad Cuajimalpa, Ciudad de México 05348, Mexico.
- Unidad de Desarrollo e Investigación en Bioterapéuticos (UDIBI), Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de México 11340, Mexico.
- Laboratorio Nacional de Vacunología y Virus Tropicales, Escuela Nacional de Ciencias Biológicas (ENCB), Instituto Politécnico Nacional, Ciudad de México 11340, Mexico.
- Coordinación de la Investigación Científica, Red de Apoyo a la Investigación, Universidad Nacional Autónoma de México, Ciudad Universitaria, Ciudad de México 14080, Mexico.
- Departamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV-IPN), Apartado Postal 07360, Ciudad de México 07360, Mexico.
ORCID-Profile: Nicolas Villegas-Sepúlveda, Leopoldo Santos-Argumedo, Sonia Mayra Pérez-Tapia, Gabriela Hernández-Galicia, Ana Beatriz Sánchez-Argáez, Paola Briseño-Díaz, Carmen Sánchez-Torres, Arturo Aguilar-Rojas, Miguel Vargas, Rosaura Hernández-Rivas
Förderung
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación
- Consejo Nacional de Ciencia y Tecnología fellowship
Zitieren
APA
Medrano-Silva, M., Salmerón-Bárcenas, E. G., Arechaga-Ocampo, E., Villegas-Sepúlveda, N., Santos-Argumedo, L., Pérez-Tapia, S. M., Padilla-Cristerna, M. L., Hernández-Montes, G., Hernández-Galicia, G., Sánchez-Argáez, A. B., Briseño-Díaz, P., Sánchez-Torres, C., Aguilar-Rojas, A., Martínez-Zayas, A., Vargas, M., & Hernández-Rivas, R. (2025). MicroRNAs Let-7b-5p and miR-24-3p as Potential Therapeutic Agents Targeting Pancreatic Cancer Stem Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262211066
Vancouver
Medrano-Silva M, Salmerón-Bárcenas EG, Arechaga-Ocampo E, Villegas-Sepúlveda N, Santos-Argumedo L, Pérez-Tapia SM, et al. MicroRNAs Let-7b-5p and miR-24-3p as Potential Therapeutic Agents Targeting Pancreatic Cancer Stem Cells. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262211066
BibTeX
@article{MedranoSilva2025,
author = {Medrano-Silva, Maricela and Salmerón-Bárcenas, Eric Genaro and Arechaga-Ocampo, Elena and Villegas-Sepúlveda, Nicolas and Santos-Argumedo, Leopoldo and Pérez-Tapia, Sonia Mayra and Padilla-Cristerna, Mayte Lizeth and Hernández-Montes, Georgina and Hernández-Galicia, Gabriela and Sánchez-Argáez, Ana Beatriz and Briseño-Díaz, Paola and Sánchez-Torres, Carmen and Aguilar-Rojas, Arturo and Martínez-Zayas, Andrea and Vargas, Miguel and Hernández-Rivas, Rosaura},
title = {MicroRNAs Let-7b-5p and miR-24-3p as Potential Therapeutic Agents Targeting Pancreatic Cancer Stem Cells},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262211066}
}
EUVIMED